Bioshield: Linking Bioscience, Biosecurity and Strategic Plan for Biodefense in Pandemics

Biosecurity in Pandemics

  • Wasim Sajjad National University of Medical Sciences, Rawalpindi
Keywords: Biosecurity, Pandemics Bio shield, Biorisk, Bioterrorism, Biopreparedness

Abstract

Biological threats, whether intentional, unintentional or natural are considered most dangerous hazards worldwide, seriously affecting the health system and global economy. In 21st century where scientists were busy to create superhuman, COVID-19 outbreak spread to 212 countries, struck the world and we found ourselves ill equipped as international comity to defeat the virus. The economic, health and political foundation were shacked globally and exposed the global health security system due to poor implementations of the policy guidelines. Similarly, Pakistan being an endemic region for emerging and reemerging infectious diseases, encountered badly by numerous different outbreaks in past. Pakistan share border with China, India, Iran and Afghanistan and increase influx of travelers through both air and land route puts Pakistan at high risk to the infectious agents. In 21st century the game of bio warfare cannot be eliminated and pose significant challenges to the security. Countries who learned from past like Korea, China with best preparedness readiness and response tackled the situation as they have best biosecurity, biorisk management system. Biosecurity as biodefense against outbreaks, pandemics, biological warfare and bioterrorism has been underestimated in developing countries like Pakistan and therefore need to highlight the urgency at national level to cope with any future outbreaks. Risk assessment, and mitigation strategies through collaborative work should need to adopt by stakeholders for strategic plan of biosecurity. Better means to protect military, health care workers operating in difficult environment are also needed. A national biosecurity system in response to outbreaks, prioritizing the emergency R&D in diagnostics, establishing high containment facilities, vaccination should be initiated. Moreover, a permanent national defense force or bio-umbrella on biosecurity should be established to shield the country from biological, chemical, nuclear and radiological threat agents. National Biological Defense Program (NBDP) should be initiated to train and protect military personnel against wide range of biological threat.

References

MacIntyre R. The risk of selective investment in downstream pandemic planning. Global Biosecurity. 2019; 1: 85-90.

Shangguan Z, Wang MY, Sun W. What caused the outbreak of COVID-19 in China: From the perspective of crisis management. International Journal of Environmental Research and Public Health. 2020; 17: 3279.

David Quammen. Spillover Warning: How We Can Prevent the Next Pandemic. 2020

Ahmad T, Haroon H, Dhama K, Sharun K, Khan FM, Ahmed I, et al. Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review. Turkish journal of biology. 2020; 44: 132-45.

Suk JE, Zmorzynska A, Hunger I, Biederbick W, Sasse J, Maidhof H, et al. Dual-use research and technological diffusion: reconsidering the bioterrorism threat spectrum. PLoS Pathog. 2011; 7: e1001253.

Imperiale MJ, Casadevall A. A new approach to evaluating the risk–benefit equation for dual-use and gain-of-function research of concern. Frontiers in bioengineering and biotechnology. 2018; 6: 21.

Sell TK, Watson M. Federal agency biodefense funding, FY2013-FY2014. Biosecurity and bioterrorism: Biodefense strategy, practice, and science. 2013; 11: 196-216.

https://www.icao.int/covid/cart/Pages/CART-Report--- Executive-Summary. aspx

https://www.iata.org/contentassets/4cb32e19ff544df5 90f3b70179551013/biosecurity-air-transport.pdf

McKirdy SJ, O'Connor S, Thomas ML, Horton KL, Williams A, Hardie D, et al. Biosecurity risks posed by a large sea-going passenger vessel: challenges of terrestrial arthropod species detection and eradication. Scientific reports. 2019; 9: 1-4.

Heckert RA, Reed JC, Gmuender FK, Ellis M, Tonui W. International biosafety and biosecurity challenges: Suggestions for developing sustainable capacity in low- resource countries. Applied Biosafety. 2011; 16: 223-30.

Sture J, Whitby S, Perkins D. Biosafety, biosecurity and internationally mandated regulatory regimes: compliance mechanisms for education and global health security. Medicine, Conflict and Survival. 2013; 29: 289-321.

https://www.legislation.gov.au/Details/C2017C00303.

Khalil A, Tanveer F, Shinwari ZK. Pakistan's bio- preparedness with regard to biosecurity, biodefense strategies and policy measures. Journal of Bioterrorism & Biodefense. 2015; 6: 2.

Meyer J. Anthrax Investigation Should Be Investigated, Congressmen Say. Los Angeles Times. 2008.

Australian Government Inspector-General of Biosecurity. Military biosecurity risk management in Australia. Review report No. 2018-19.

Török TJ, Tauxe RV, Wise RP, Livengood JR, Sokolow R, Mauvais S, et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. Jama. 1997; 278: 389-95.

Kolavic SA, Kimura A, Simons SL, Slutsker L, Barth S, Haley CE. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination. Jama. 1997; 278: 396-8.

Berger KM, DiEuliis D, Meyer C, Rao V. Roadmap for biosecurity and biodefense policy in the United States. J Health Security. 2018.

Ye L. The United States issues national biodefense strategy. Journal of Biosafety and Biosecurity. 2019; 1: 3-4.

Abid K, Bari YA, Younas M, Javaid ST, Imran A. Progress of COVID-19 Epidemic in Pakistan. Asia-Pacific Journal of Public Health. 2020 May 19.

Huigang L, Xiaowei X, Cui H, Haixia M, Zhiming Y. A brief history of the development of infectious disease prevention, control, and biosafety programs in China. Journal of Biosafety and Biosecurity. 2020; 1: 56–8.

Castriciones EV, Vijayan V. Biosecurity risk mapping and gap analysis in South East Asia. Journal of Biosafety and Biosecurity. 2020.

Wiener SL. Strategies of biowarfare defense. Military medicine. 1987; 152: 25-8.

Collins BJ. NATO: A Guide to the Issues. ABC-CLIO.2011.

Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25: 5086-96.

Epstein SB, Lister SA, Belasco A, Jansen DJ. FY2015 Funding To Counter Ebola And The Islamic State (IS). International Journal of Terrorism & Political Hot Spots. 2015.

CDC Ebola response in the United States and abroad. 2015.

Jonas O, Parry I, Chisholm D, Banatvala N, Ladminarayan R.

Global health threats of the 21st century. Finance and Development. 2014; 51: 16-20.

McKibbin WJ. Economic modeling of sars: The g-cubed approach. Prepared for handbook on the rapid assessment of the economic impact of public health emergencies of international concern. World Health Organisation. 2004.

Fan VY, Jamison DT, Summers LH. The inclusive cost of pandemic influenza risk. National Bureau of Economic Research. 2016.

Burns A, Van der Mensbrugghe D, Timmer H. Evaluating the economic consequences of avian influenza. Washington, DC: World Bank. 2006.

Nguyen TH, Coca-Stefaniak JA. Coronavirus impacts on post-pandemic planned travel behaviours. Annals of Tourism Research. 2020; 28: 102964.

Schoenbaum SC. Economic impact of influenza: the individual's perspective. The American Journal of Medicine. 1987; 82: 26-30.

Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerging infectious diseases. 1999; 5: 659. 36. Merianos A, Peiris M. International health regulations (2005). The Lancet. 2005; 366: 1249-51.

Fidler DP. From international sanitary conventions to global health security: the new International Health Regulations. Chinese Journal of International Law. 2005; 4: 325-92.

Allen J, Burns N, Garrett L, Haass RN, Ikenberry GJ, Mahbubani K, et al. How the world will look after the

coronavirus pandemic. Foreign Policy. 2020; 20: 2020.

Koblentz GD. Biosecurity reconsidered: calibrating biological threats and responses. International security.

; 34: 96-132.

Dillon M, Lobo-Guerrero L. Biopolitics of security in the 21st century: An introduction. Review of International Studies. 2008; 1: 265-92.

COVID W. PHEIC Global research and innovation forum: towards a research roadmap.

Sun N, Wei L, Shi S, Jiao D, Song R, Ma L, et al. A qualitative study on the psychological experience of caregivers of COVID-19 patients. American journal of infection control. 2020; 48: 592-8.

Gap GG. World economic forum. Cologny/Geneva. 2017. 44. Luong TA. Globalization and infectious diseases: Evidence on the reproduction rate of the COVID-19 pandemic. Tuan Luong and Thu hang Nguyen, (2020)' Globalization and Infectious Diseases: Evidence on the Reproduction Rate of the COVID-19 Pandemic', Economics Bulletin. 2020; 40:1675-85.

Chigas D. Track II Resources. 2014; https://www.sfcg.org/track-ii-resources/. Accessed 29 August 2019.

Chigas D. Track II (Citizen) Diplomacy, Beyond Intractability. Org. 2003.

European Commission's Joint Research Centre (JRC). EU Chemical, Biological, Radiological and Nuclear Risk Mitigation Centres of Excellence (CoE). 2019; https://ec.europa.eu/jrc/en/research-topic/chemical- biological-radiological-andnuclear-hazards/cbrn-risk- mitigation-centres-of-excellence. 2019.

Ayotte K, Gerberding J, Morrison JS. Ending the Cycle of Crisis and Complacency in US Global Health Security. 2019.

Published
2020-12-23